$AMBA Recent News Why GoPro’s stock keeps crashing

New Post Public Reply Private Reply Replies (0) Message Board

Jan 3, 2015 at 12:49 PM

$AMBA Recent News

Why GoPro’s stock keeps crashing 11:48 a.m. Dec. 10, 2014 - Jennifer Booton
EBay a rare gainer in weak tech session 4:47 p.m. Dec. 8, 2014 - Rex Crum
Yahoo, Google get attention from tech investors 4:29 p.m. Dec. 5, 2014 - Rex Crum
Cypress-Spansion deal paces tech gains 4:42 p.m. Dec. 2, 2014 - Rex Crum
GoPro losses stand out in weak tech trading action 9:42 a.m. Nov. 20, 2014 - Rex Crum
GoPro rises, even with CEO’s plan to cash in shares 2:58 p.m. Nov. 18, 2014 - Rex Crum
When we sell 2:23 p.m. Nov. 18, 2014 - Cody Willard
GoPro gains stand out in tech’s advance 11:43 a.m. Nov. 18, 2014 - Rex Crum
GoPro, Ambarella shares lead tech advance 10:07 a.m. Nov. 18, 2014 - Rex Crum
3 growth industries revolutionizing the world 5:12 p.m. Nov. 17, 2014 - Cody Willard
4 near-term catalysts for the next stock market crash 2:45 p.m. Nov. 10, 2014 - Cody Willard
Major U.S. benchmarks digest the breakout 9:47 a.m. Nov. 10, 2014 - Michael Ashbaugh
Analyzing diversification strategies 2:29 p.m. Oct. 14, 2014 - Cody Willard
Microchip’s revenue warning short circuits semiconductor sector 2:38 p.m. Oct. 10, 2014 - Rex Crum
Ambarella is the go-to name for GoPro 2:34 p.m. Sept. 25, 2014 - Rex Crum
Nasdaq Composite violates first support 11:38 a.m. Sept. 15, 2014 - Michael Ashbaugh
Apple, GoPro gains help boost tech stocks 4:24 p.m. Sept. 5, 2014 - Rex Crum
Wearing the Wearables Revolution 3:33 p.m. Aug. 26, 2014 - Cody Willard
The Wearables Revolution is the biggest market ever 3:41 p.m. Aug. 5, 2014 - Cody Willard
How to position yourself post-pullback 11:44 a.m. Aug. 4, 2014 - Cody Willard

Should Microchip Technology Be in Your Portfolio Now? - Analyst Blog 12:50 p.m. Jan. 2, 2015 - Zacks.com
The 10 Best Stocks to Buy for 2015 9:10 a.m. Jan. 2, 2015 - InvestorPlace.com
Investors' Radars Failed to Catch Ambarella (AMBA), Has Yours? - Tale of the Tape 9:00 a.m. Jan. 2, 2015 - Zacks.com
12 “Triple A” Stocks to Buy 1:30 a.m. Jan. 2, 2015 - InvestorPlace.com
Atmel Upgraded to Hold on Sustained Product Launches - Analyst Blog 10:35 a.m. Dec. 31, 2014 - Zacks.com
3 Semiconductor Stocks to Buy Now 1:15 a.m. Dec. 31, 2014 - InvestorPlace.com
SunEdison (SUNE) Down to Strong Sell: Should You Dump It? - Analyst Blog 1:30 p.m. Dec. 30, 2014 - Zacks.com
GoPro sales look strong as camera inventories go lean 10:47 a.m. Dec. 30, 2014 - Investors Business Daily
GoPro Gets Lift From Pacific Crest Comments 10:43 a.m. Dec. 30, 2014 - benzinga.com
MagnaChip Inks Research Pact to Make Magnetic Bio-Sensors - Analyst Blog 10:00 a.m. Dec. 30, 2014 - Zacks.com
Ambarella (AMBA) Stock Higher Today as GoPro Supplier Benefits from 'Strong' Holiday Demand 9:29 a.m. Dec. 30, 2014 - TheStreet.com
Best Stocks for 2015 – AMBA Powers Up for Even More Growth 2:59 a.m. Dec. 30, 2014 - InvestorPlace.com
Needham & Co.'s Bullish and Bearish Recommendations for Semiconductor Stocks 3:08 p.m. Dec. 29, 2014 - GuruFocus.com
Here’s a Reason GoPro (GPRO) Stock is Falling Today 2:29 p.m. Dec. 29, 2014 - TheStreet.com
Perilous Reversal Watch: Ambarella (AMBA) 9:45 a.m. Dec. 29, 2014 - TheStreet.com
Will Ambarella (AMBA) Stock be Hurt Today by This Analyst Downgrade? 9:28 a.m. Dec. 29, 2014 - TheStreet.com
Analysts' Actions: Ambarella, Gilead, Halyard Health and More 8:21 a.m. Dec. 29, 2014 - TheStreet.com
Needham downgrades SWKS, RFMD, TQNT, AMBA, CAVM, MXL 8:05 a.m. Dec. 29, 2014 - Seeking Alpha
Needham Downgrades Ambarella To Underperform 6:37 a.m. Dec. 29, 2014 - benzinga.com
2 Tech Stocks to Buy Before 2015 12:30 a.m. Dec. 26, 2014 - InvestorPlace.com

Critical Alerts For Linn Energy, Delta Airlines, Herbalife, Ambarella and NPS Pharmaceuticals Released By InvestorsObserver 9:31 a.m. Dec. 17, 2014 - PR Newswire - PRF
Semiconductors Stocks on the Move - Ambarella, Cree, Skyworks Solutions, TriQuint Semiconductor, and Xilinx 8:30 a.m. Dec. 16, 2014 - PR Newswire - PRF
Ambarella Receives GSA Award for Most Respected Emerging Public Semiconductor Company 6:45 p.m. Dec. 12, 2014 - BusinessWire - BZX
Ambarella, Inc. Announces Third Quarter Fiscal 2015 Financial Results 4:05 p.m. Dec. 4, 2014 - GlobeNewswire
Critical Alerts For Apple, Ambarella, Cliffs Natural Resources, Keryx Biopharmaceuticals and Johnson Controls Released By InvestorsObserver 9:31 a.m. Nov. 18, 2014 - PR Newswire - PRF
Ambarella Announces Q3 FY 2015 Earnings Conference Call to be Held Dec. 4, 2014 8:01 a.m. Nov. 17, 2014 - GlobeNewswire
Critical Alerts For Mobileye NV, Schlumberger, Ambarella, Walter Energy and Inovio Pharmaceuticals Released By InvestorsObserver 9:31 a.m. Nov. 3, 2014 - PR Newswire - PRF
Technical Recap on Semiconductors Equities - Canadian Solar, ARM Holdings, Maxim Integrated Products, Freescale Semiconductor, and Ambarella 7:45 a.m. Oct. 31, 2014 - PR Newswire - PRF
Ambarella S3 IP Camera SoC Delivers Outstanding 4K Video Quality Using State-of-the-Art H.265/HEVC Encoding 7:02 a.m. Oct. 22, 2014 - BusinessWire - BZX
Corporate Initiatives, Upcoming Events, Filings, and Refueling Outages - Research Reports on LinkedIn, Ambarella, Western Digital, NiSource and Exelon 7:30 a.m. Oct. 2, 2014 - PR Newswire - PRF
Critical Alerts For Gilead Sciences, Ambarella, American Capital Agency, NetApp and Ford Released By InvestorsObserver 9:33 a.m. Sept. 24, 2014 - PR Newswire - PRF
Critical Alerts For Gilead Sciences, Ambarella, American Capital Agency, NetApp and Ford Released By InvestorsObserver 8:37 a.m. Sept. 24, 2014 - PR Newswire - PRF
Post-Earnings Review – Ambarella 8:15 a.m. Sept. 16, 2014 - PR Newswire - PRF
Product Enhancement, Public Offering of Shares, Quarterly Results, Strategic Agreements, and Interim Dividend - Research Reports on Splunk, Sensata, Ambarella, Sprint and Avago 7:50 a.m. Sept. 10, 2014 - PR Newswire - PRF
Ambarella, Inc. Announces Second Quarter Fiscal 2015 Financial Results 3:05 p.m. Sept. 4, 2014 - GlobeNewswire
Ambarella to Present at the Deutsche Bank Conference Sept. 9, 2014 7:01 a.m. Aug. 28, 2014 - GlobeNewswire
Stocks Coverage on the Semiconductors Industry -- Cree, Ambarella, Taiwan Semiconductor Manufacturing, Applied Micro Circuits, and ON Semiconductor 7:40 a.m. Aug. 27, 2014 - PR Newswire - PRF
Ambarella Announces Q2 FY 2015 Earnings Conference Call to be Held Sept. 4, 2014 7:01 a.m. Aug. 20, 2014 - GlobeNewswire
Atonarp Inc. Raises $8M Series A Round Led by Walden Riverwood Ventures 9:00 a.m. Aug. 12, 2014 - BusinessWire - BZX
Financial Results, Scheduled Conferences, and Appointments - Research Reports on IPG Photonics, Teradyne, KLA-Tencor, Ambarella and Kulicke and Soffa 7:40 a.m. Aug. 1, 2014 - PR Newswire - PRF

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

BAIC FOTON Eyes African Market with Strategic Moves

Revving Up for Africa Alright, gearheads and number-crunchers, strap in. BAIC FOTON is making headlines again, and this time they’re zooming right into Africa—like they're claiming pole position on a circuit that's been ignored by many. They’re calling it a “Drive to Great!” but what does that mean for us investors who aren’t just in it for the entertainment?...

RYBREVANT's Promising Results in HNSCC Treatment

Impressive Outcomes for RYBREVANT FASPRO in Head and Neck Cancer Tucked away in the endless cycle of drug trials, a glimmer of hope shines through with new data on RYBREVANT FASPRO in treating head and neck squamous cell carcinoma (HNSCC). This science talk might not rattle the ticker tape directly on NYSE:JNJ, but it has all the makings of a game-changer in the oncology...

Sac-TMT's Phase III Success Shifts Lung Cancer Paradigm

A New Era in Lung Cancer Treatment? Sac-TMT, the novel antibody-drug conjugate (ADC), just might be shaking up the non-small cell lung cancer (NSCLC) treatment landscape, and boy, is it making waves. Just when you think you’ve seen it all, here comes sacituzumab tirumotecan (sac-TMT), offering a glimmer of hope for patients whose treatment options have dwindled after...

Dr. Boonipat Inspires Future Women Surgeons at Texas Tech

Sowing Surgical Seeds in Lubbock In Lubbock, Texas, something meaningful unfolded—an event the big market players would hardly blink at, but a significant step for the future of medicine. Led by Dr. Thanapoom "Mo" Boonipat, the founder of FacePlus Plastic Surgery Institute, a unique suturing workshop provided premed students at Texas Tech University hands-on experience...

Gildan Activewear Faces Legal Battle Over Alleged Fraud

Investor Alert: Gildan's Legal Showdown Alright, here's a twist you didn't see coming—or maybe you did if you've been tracking the ticker tapes like a hawk. Gildan Activewear Inc. (NYSE:GIL) is stuck in the kind of hot water that can scald the bottom line. The Stakes: Racing Towards December 14 Marked on your calendar, December 14, is a date of some significance if...

Hims & Hers Faces FTC Heat: Investor Class Action Looms

Trouble Is Brewing for Hims & Hers Investors This isn't your typical quiet stroll through the park when it comes to Hims & Hers Health, Inc. (NYSE: HIMS). We're talking about a full-blown legal showdown that's unfolding faster than you can say 'telehealth scandal.' October 25, 2026, saw the kind of announcement that makes seasoned investors' hearts skip a beat if they've...

Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Firefox Champions Privacy with Iconic Internet Campaign

Rekindling the Internet’s Golden Days with Firefox There’s something almost poetic about Firefox hustling to win back its old users by launching a campaign with legendary internet icons. The backdrop? A digital landscape where privacy feels about as common as a unicorn sighting. Mozilla's pulling a major nostalgia card, and I'm here for it—sort of like how vinyl...

Ivonescimab Promises New Hope for Advanced BTC Patients

Shifting the Paradigm in Biliary Tract Cancer Treatment Here's the scoop from the bustling world of oncology: the trial of Ivonescimab plus chemotherapy is stirring waves among experts in advanced biliary tract cancer (BTC). Contrary to the usual drowsy mornings with coffee and market pages, this data from Hong Kong wasn't about Wall Street this time. This trial might...